In FDA adcomm, Lexicon gets another thumbs down for sotagliflozin – FiercePharma
In FDA adcomm, Lexicon gets another thumbs down for sotagliflozin FiercePharma Source link
In FDA adcomm, Lexicon gets another thumbs down for sotagliflozin FiercePharma Source link
Eli Lilly’s shortage of diabetes and obesity drugs is over, halting competition with knock-offs FiercePharma Source link
Bayer builds entire ‘ecosystem’ around One A Day cell health support supplement FiercePharma Source link
Amid GLP-1 boom, Novo Nordisk strikes up insulin partnership in Indonesia FiercePharma Source link
Novo’s Ozempic, Wegovy linked to potential eye problem? Not so fast, analysts say FiercePharma Source link